News Sentiment

ADGM sentiment intelligence

Adagio Medical Holdings, Inc Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 64 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 0.57 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 64

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-10.5% over one week, -23.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -10.5% Price reacting lower
Trend fit Trend inactive -23.5% over four weeks
Fair value -65.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 45
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 64
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 15
TradingView 7
TradingKey 6
Stock Titan 4
Investing.com 4
Barron's 3
StockStory 3
Medical Product Outsourcing 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 23
Regulatory and legal 5
Analyst action 3
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 64
Orange County Business Journal Direct company coverage

Adagio Medical Seeks FDA OK for Heart Device

Adagio Medical Holdings Inc. has submitted a premarket approval (PMA) application to the FDA for its vCLAS Ventricular Ablation System, a device designed to treat ventricular tachycardia using cryoablation technology. This development follows CE Mark approval in the EU and positi

Tone
Positive 62/100
Event
Regulatory and legal
Published
01 Jun 2026 15:39
Source
Orange County Business Journal
Finviz Direct company coverage

ADGM - Adagio Medical Holdings Inc Stock Price and Quote

This page provides a detailed financial overview of Adagio Medical Holdings Inc. (ADGM), a medical device company focused on developing ablation technologies for cardiac arrhythmias. It includes current stock price, key financial metrics, recent news, analyst ratings, and insider

Tone
Positive 70/100
Event
Analyst action
Published
26 May 2026 19:39
Source
Finviz
Investing.com Nigeria Direct company coverage

Adagio Medical submits FDA application for VT ablation system By Investing.com

Adagio Medical Holdings Inc. has submitted a Premarket Approval application to the FDA for its vCLAS Ventricular Ablation System, designed to treat drug-refractory ventricular tachycardia. The application is supported by positive data from its FULCRUM-VT trial, which showed high

Tone
Neutral 50/100
Event
Regulatory and legal
Published
22 May 2026 15:38
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Adagio Medical (ADGM) files FDA PMA for vCLAS ventricular tachycardia ablation system

Adagio Medical Holdings, Inc. (ADGM) has submitted a Premarket Approval (PMA) application to the FDA for its vCLAS Ventricular Ablation System to treat drug-refractory ventricular tachycardia. The application is backed by strong pivotal trial data, showing high acute clinical suc

Tone
Positive 73/100
Event
Regulatory and legal
Published
22 May 2026 04:39
Source
Stock Titan
BioSpace Direct company coverage

Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia

Adagio Medical has submitted a Premarket Approval (PMA) application to the FDA for its vCLAS® Ventricular Ablation System, designed to treat drug-refractory, recurrent ventricular tachycardia. This submission is supported by positive data from the FULCRUM-VT pivotal trial, which

Tone
Positive 72/100
Event
Regulatory and legal
Published
22 May 2026 02:26
Source
BioSpace